|Articles|September 14, 2017

Corneal hysteresis indicator for glaucoma progression

Justin Schweitzer, OD, in Sioux Falls, SD, examines corneal hysteresis and discusses how it may be an indicator for glaucoma progression in patients at Vision Expo West in Las Vegas, NV.

Get more content here from Vision Expo West in Las Vegas, NV

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related to this article

Optometrists examining an OCT Scan | Image Credit: Adobe Stock/Maria Vitkovska

October 23rd, 2026

Study: OCTA analysis tools report different macular vessel density values for glaucoma

Open-access OCTA tools showed similar reliability, but different vessel density values in glaucoma; researchers advise using one tool consistently.

October 22nd, 2026

BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial

Interim 48-month data show 86% of patients with glaucoma or ocular hypertension remain off topical drops after a single cataract procedure, although the drop-free rate has eased from earlier timepoints.

October 26th, 2026

Where contact lens wearers cut corners and what it can cost them

Zachary Keaney, CPOA, discusses the lens care steps patients skip most often and why early diagnosis of lens-related keratitis is critical.

Takeaways from this week in optometry | Image Credit: Canva

October 24th, 2026

Takeaways from this week in optometry: October 16-23

This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more.

Man suffering from uveitis | Image Credit: Adobe Stock/Alessandro Grandini

October 22nd, 2026

Brepocitinib for noninfectious uveitis meets all phase 3 trial end points

CLARITY program data show significantly longer time to treatment failure and higher rates of steroid-free quiescence vs placebo.

Behrad Garmsiri, OD, MS (left), and Bryce St. Clair, OD, MPH, FAAO

October 22nd, 2026

More than monitoring: Using AMD visits to promote healthy vision aging

Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future interventions for patients with AMD.